Not yet: Neurotransplantation as a treatment for parkinson disease reached the stage of human trials over 15 years ago, but the field, which is still in its infancy, has encountered a number of roadblocks since then, both political and scientific. With hope that stem cells may be used as a new source of dopaminergic neurons to replace the degenerating nerve cells in parkinson disease looming.
Answered 9/5/2020
5.9k views
Outside the U.S.: I am only aware of clinical trials outside the us for the treatment of parkinson's. Ongoing trials for the treatment of Parkinson's exist in mexico, china, thailand, and india. They are using bone marrow and adipose tissue as sources of mesenchymal stem cells. Msc's and their mechanisms are believed to be the cells which do the healing.
Answered 2/18/2015
5.8k views
In clinical trials: Use of adult mesenchymal stem-stromal cells (mscs) are currently in clinical trial in us/internationally. Trend is toward use of fat derived mscs, havested by liposuction, isolated and concentrated in tissue culture. Early reports suggest significant improvement in neurological, autoimmune and organ functions. Many more mscs in fat than bone marrow making ad-msc the center of most research now.
Answered 7/25/2014
5.7k views
SC& Parkinsons: No. Further research is needed to determine if and how to develop the needed neuronal type.
Answered 7/25/2014
5.6k views
A doctor has provided 1 answer
5 doctors weighed in across 3 answers
A doctor has provided 1 answer
5 doctors weighed in across 3 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question